These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3689442)

  • 21. Complexes of nitracrine with DNA. Stoichiometry of binding.
    Szmigiero L; Gniazdowski M
    Arzneimittelforschung; 1981; 31(11):1875-7. PubMed ID: 7198467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR studies of configuration and tautomeric equilibria in nitroacridine antitumor agents.
    Boyd M; Denny WA
    J Med Chem; 1990 Sep; 33(9):2656-9. PubMed ID: 2391704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.
    Gniazdowski M; Ciesielska E; Szmigiero L
    Chem Biol Interact; 1981 Mar; 34(3):355-66. PubMed ID: 6161711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
    Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free radical metabolism of mutagenic acridines and binding to microsomal membranes.
    Sinha BK
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1166-71. PubMed ID: 6277329
    [No Abstract]   [Full Text] [Related]  

  • 26. DNA polyintercalation: comparison of DNA binding properties of an acridine dimer and trimer.
    Gaugain B; Markovits J; Le Pecq JB; Roques BP
    FEBS Lett; 1984 Apr; 169(2):123-6. PubMed ID: 6714420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis".
    Denny WA; Atwell GJ; Anderson RF; Wilson WR
    J Med Chem; 1990 May; 33(5):1288-95. PubMed ID: 2329552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Formation of a complex of spin label 9-aminoacridine with DNA and polynucleotides].
    Mil' EM; Zhil'tsova VM; Krinitskaia LA; Krugliakova KE
    Izv Akad Nauk SSSR Biol; 1980; (4):512-18. PubMed ID: 6251123
    [No Abstract]   [Full Text] [Related]  

  • 30. The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNA.
    Pawlak K; Matuszkiewicz A; Pawlak JW; Konopa J
    Chem Biol Interact; 1983 Feb; 43(2):131-49. PubMed ID: 6825197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
    Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
    J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent binding of 1-nitro-9-(3-dimethyl-n-propylamino) acridine, a new antitumor drug, to DNA of Ehrlich ascites tumor cells in vivo.
    Konopa J; Koldej K; Pawlak JW
    Chem Biol Interact; 1976 Apr; 13(1):99-103. PubMed ID: 1260948
    [No Abstract]   [Full Text] [Related]  

  • 33. DNA damage and cytotoxicity of nitracrine in cultured HeLa cells.
    Szmigiero L; Studzian K
    Biochim Biophys Acta; 1989 Aug; 1008(3):339-45. PubMed ID: 2758032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective deactivation of ICR mutagens as related to their distinctive pulmonary carcinogenicity.
    De Flora S; Morelli A; Zanacchi P; Bennicelli C; De Flora A
    Carcinogenesis; 1982; 3(2):187-94. PubMed ID: 6175436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antitumor properties of nitracrine and amsacrine analogs.
    Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
    Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome aberrations induced by 9-aminoacridine derivatives.
    Michalska J
    Mutat Res; 1986 Jun; 170(3):119-23. PubMed ID: 3713722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMINO GROUP REACTIVITY IN DNA--AMINOACRIDINE COMPLEXES.
    LERMAN LS
    J Mol Biol; 1964 Dec; 10():367-80. PubMed ID: 14255106
    [No Abstract]   [Full Text] [Related]  

  • 38. 1H and 13C NMR characteristics of the anticancerous derivative of acridine: Ledakrin C-283 (nitracrine).
    Wieczorkiewicz T; Lubas B; Siatecki Z; Kozłowski H
    Acta Biochim Pol; 1983; 30(1):71-82. PubMed ID: 6868905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin and daunomycin induce interstrand DNA crosslinks in Hela S3 Cells.
    Konopa J
    Biochem Biophys Res Commun; 1983 Feb; 110(3):819-26. PubMed ID: 6404263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking.
    Pawlak K; Pawlak JW; Konopa J
    Cancer Res; 1984 Oct; 44(10):4289-96. PubMed ID: 6467190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.